Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer.

Szymon PiatekGrzegorz PanekZbigniew LewandowskiMariusz BidzinskiDominika PiatekPrzemyslaw KosinskiMiroslaw Wielgos

Published in: Journal of ovarian research (2020)

Increased concentration of CA-125 by > 5 U/ml within normal range, 3 and 6 months after treatment was unfavorable prognostic factor in ovarian cancer patients with complete response to primary therapy.

Keyphrases

prognostic factors
free survival
protein kinase
bone marrow
smoking cessation